How can three landmark trials of intensive vs standard glucose-lowering strategies — ADVANCE, ACCORD, and VADT — raise more questions than they answer?… 

Testing for peripheral neuropathy may provide a way to identify individuals at higher risk of cardiovascular events…. 

Study seems to indicate superiority of dulaglutide, a long-acting GLP-1 receptor agonist that is administered once-weekly…. 

The effects of caffeine versus maltodextrin during exercise were observed in patients with type 2 diabetes…. 

Initial findings suggest relationship but with sibling-control analyses, effect almost disappears….

A BMI of more than 25 kg/m seems to be a protective factor for renal function deterioration in some patients…. 

Displacement of high glycemic-index carbohydrates and high and monounsaturated fat content may explain the positive effects….

Rates for patients with diabetes are two times higher in low-income neighborhoods compared to high-income neighborhoods in California…. 

Sometimes when we prepare this newsletter, the articles, slides and text all seem to go together. That is very evident when we look at the Clinical Text from Drs. Rudy Bilous and Richard Donnelly, as they talk about the epidemiology of type 2 diabetes. This week, they delve into a lot …

Diabetes is a huge and growing problem, and the costs to society are high and escalating. In the Western Pacific, 138 million adults have diabetes – the largest number of any region. The Top 5 countries for prevalence in this region are: China, Indonesia, Japan, Korea (Republic of), and Viet …